Fabio Cury

Radiation Oncologist @cusm_muhc | Assistant Professor @mcgill |Father&Husband | Brown belt @gbmontreal #graciebarra | 🇨🇦🇧🇷 | Educator/Learner

[Piet Ost @piet_ost]

🔬 10-year HYPO-RT-PC trial update:
UHF 📆2.5 weeks 7# = CF 📆8 weeks 39#

✅ Same survival & toxicity
➡️ UHF may be more efficient!
#ESTRO25 #ProstateCancer

[Alison Allan, PhD @DrAlisonAllan]

🇨🇦🇨🇦 Goosebumps. #ResearchMatters #EndIt

[Vivian Tan MD @drviviantan]

🔥Hot off the press @EurUrolOncol

IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc

https://t.co/hogLg40zkk

Thankful for mentors @_ShankarSiva
@DrAlexLouie @DrCorreaRO

[Ramy Saleh, MD, MSc @Ramysaleh86]

Medical Oncology #fellowship program is open again!! #GUtumors , #Sarcoma, #ClinicalTrials and others. Apply if interested, fellowships are paid!
applications are open 🥼 at @McgillOncology https://t.co/qogQ6hXLRW

[Fabio Cury @dr_cury]

@PaulSargos @gusviani @dodieboymd @OncoAlert @RadiotherapyOn1 @fabiomoraesmd @RadioOncologia @mcgillu Merci Paul!!! 😊

[Fabio Cury @dr_cury]

In press

[Gustavo @gusviani]

🎙️5-day RT preop courses result in ⬆️ LC, high R0 margins and acceptable complication rates in #sarcoma ‼️@OncoAlert @RadiotherapyOn1 @fabiomoraesmd @RadioOncologia @dr_cury
📌Meta analysis➡️9 studies: 786 👥, 5-day pre-op RT, median 30 Gy/ 5 fr
📊RESULTS
- Local control (LC) 92.3%
- R0 margins 84.5%
- Overall survivalOS) 78%
- Distant relapse (DR) 36%
- Meta-regression: BED/ tumor size 🔁 LC and R0 margins
- Subgroup: BED ≥90 had ⬆️ LC (p < 0.0001)
- Complete pathologic response 19%
- Amputation rate 8.3%
- Wound complications 30%
- Fibrosis grade 2+ 6.4%
#radonc #surgery https://t.co/WNYmq45UPc

[Vivian Tan MD @drviviantan]

Excited for an oral presentation on #IROCK at #ASTRO2023 in San Diego! Thank you for the support

@DrCorreaRO @DrAlexLouie @_ShankarSiva @dr_alimuhammad @AMuacevic @LPonsky @SimonLo21054188 @ASwaminathMD
@dr_cury @MichaelStaehler @NicholasZaorsky
@ASTRO_org #astro23 #radonc

[Wes Kassouf @WesKassouf]

Canadian experience on 864 patients treated with #radiation based therapy for muscle invasive #bladdercancer. Results from real world experience among tertiary centres mirrors data from reported clinical trials. https://t.co/3X6r6IgdG5

[Wes Kassouf @WesKassouf]

Congrats @dr_rkool on a great talk showing benefits of whole pelvis radiation vs bladder only for #bladdercancer patients treated with #radiation …a rational approach to advocate treatment of pelvic lymph nodes to enhance cure, and similar to what is done with radical surgery

[Wes Kassouf @WesKassouf]

We are hiring an assistant professor who will focus on #immunology and #bladdercancer @McGillDeptSurg @cusm_muhc @mcgillu strong and supportive academic environment in the wonderful city of @montreal please apply or RT https://t.co/vxeDDfHtMa

[Nicholas Zaorsky, MD MS @NicholasZaorsky]

Kidney cancer staging in one figure.

#KidneyCancer
@AJCCancer 8th ed

[Shankar Siva @_ShankarSiva]

Trimodality bladder preservation versus cystectomy for muscle invasive bladder cancer; matched cohort #ASTRO22 @OncoAlert. Dr J Efstathiou - outcomes similar for TMT versus cystectomy. 13% required salvage cystectomy, but did not impact survival. Hydronephrosis a bad player ☹️

[Andre G, MD, Rad Onc ⚽️ 🇮🇹 🇨🇦 @RadioOncologia]

Meta-analysis of elective pelvic nodal irradiation
Final version just released! Congrats: @gusviani @dr_cury @fabiomoraesmd

https://t.co/hgyRYasffZ

[Dr. Fabio Moraes @fabiomoraesmd]

“Meta-analysis of elective pelvic nodal irradiation using moderate hypofractionation for high-risk prostate cancer” (MENHYP-ENI) https://t.co/KjXc7K3FE3 @RadioOncologia @gusviani @dr_cury

[Canadian Urological Association @CanUrolAssoc]

Happening now!
DAY 1 | CANADIAN BLADDER CANCER FORUM 22
Thank you to our speakers #CBForum22
If you want to join us tomorrow, register here:https://t.co/o35OvtB93X
@pcvblack @kalasri3 @lalaniMD @CanImmun @siemensr @dr_cury

[Andre G, MD, Rad Onc ⚽️ 🇮🇹 🇨🇦 @RadioOncologia]

Educação continuada em radioterapia. Aula hoje sobre câncer de bexiga com o Dr. Fabio Cury @dr_cury

[Wes Kassouf @WesKassouf]

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy. https://t.co/68yZmKR4dx @dr_rkool

[Todd C. Lee @DrToddLee]

Third dose received. Merci palais des congrès team for accommodating healthcare workers in the absence of a coordinated response in some hospitals.

[Fabio Cury @dr_cury]

It was a pleasure to share the stage (or the screen) with old and new friends and talk about Sarcoma at the #semanaonco. @alegronchi - hoping to see you in person, in Brazil, soon.

[Marcelo Sá @drmarcelosa]

Muito honrado de participar, como moderador, de mais um evento da @sbco_oficial
O XV Congresso Brasileiro de Cirurgia Oncológica junto com a III Semana Brasileira de Oncologia.
Excelente discussão sobre sarcomas de partes moles. #sarcoma #cirurgiaoncologica #sbco #cancertemcura

[Thierry Alcindor, MD, MSc @Thalcin]

In anticipation of #ctos2021, a group picture of ⁦@McgillSarcoma⁩: ⁦@SinzianaDumitra⁩ , ⁦@dr_cury⁩ , myself and a few Twitterless colleagues .